Chronic wound healing by fetal cell therapy may be explained by differential gene profiling observed in fetal versus old skin cells

Experimental Gerontology

Volumn 44, Issue 3, 2009, Pages 208-218

  Ramelet, Albert Adrien ^b   Hirt Burri, Nathalie ^a   Raffoul, Wassim ^a   Scaletta, Corinne ^a,e   Pioletti, Dominique P ^d,e   Offord, Elizabeth ^c   Mansourian, Robert ^c   Applegate, Lee Ann ^a,e  

^a LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

^b Dermatology and Angiology FMH   (Switzerland)

^c NESTLÉ RESEARCH CENTER   (Switzerland)

^d EPFL   (Switzerland)

^e Department of Musculoskeletal Medicine ^*  (Switzerland)

Author keywords

Chronic wounds; Extracellular matrix; Fetal skin; Gene families; Growth factors; Leg ulcers; Tissue engineering

Indexed keywords

ADULT; AGED; ARTICLE; CELL ADHESION; CELL CYCLE; CELL MATURATION; CELL THERAPY; CHRONIC WOUND; CLINICAL ARTICLE; CLINICAL FEATURE; EXTRACELLULAR MATRIX; FEMALE; FETUS; FETUS CELL; GENE CLUSTER; GENE OVEREXPRESSION; GENETIC ANALYSIS; HUMAN; HUMAN CELL; LEG ULCER; MALE; MICROARRAY ANALYSIS; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; SKIN CELL; TISSUE ENGINEERING; TISSUE REPAIR; WOUND HEALING; ANALYSIS OF VARIANCE; BIOLOGICAL DRESSING; CELL CULTURE; CELL LINE; CLINICAL TRIAL; CYTOLOGY; DNA MICROARRAY; EMBRYOLOGY; FIBROBLAST; GENE EXPRESSION PROFILING; GENETICS; ISOLATION AND PURIFICATION; MIDDLE AGED; MULTIGENE FAMILY; PHASE 1 CLINICAL TRIAL; POLYMERASE CHAIN REACTION; PREPUCE; PROCEDURES; SKIN; SKIN TRANSPLANTATION; STATISTICS AND NUMERICAL DATA; VERY ELDERLY;

RNA;

ADULT; AGED; AGED, 80 AND OVER; ANALYSIS OF VARIANCE; BIOLOGICAL DRESSINGS; CELL LINE; CELLS, CULTURED; FEMALE; FETUS; FIBROBLASTS; FORESKIN; GENE EXPRESSION PROFILING; HUMANS; LEG ULCER; MALE; MIDDLE AGED; MULTIGENE FAMILY; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; POLYMERASE CHAIN REACTION; RNA; SKIN; SKIN TRANSPLANTATION; TISSUE ENGINEERING; WOUND HEALING;

EID: 59849114615     PISSN: 05315565     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.exger.2008.11.004     Document Type: Article

References (57)

1. Albig A.R., Neil J.R., and Schiemann W.P. Fibulins 3 and 5 antagonize antiogenesis in vivo. Cancer Res. 66 5 (2006) 2621-2629
2. Adzick N.S., and Lorenz H.P. Cells, matrix, growth factors and the surgeon: the biology of scarless fetal wound repair. Ann. Surg. 220 (1994) 10-18
3. Armstrong J.R., and Ferguson M.W.J. Ontogeny of the skin and the transition from scar free to scarring phenotype during wound healing in the pouch young of the marsupial Monodelphis domestica. Dev. Biol. 169 (1995) 242-260
4. Ashcroft G.S., Mills S.J., Lei K., Gibbons L., Jeong M.-J., Taniguchi M., Burow M., Horan M.A., Wahl S.M., and Nakayama T. Estrogen modulates cutaneous wound healing by downregulating macrophage migration inhibitory factor. J. Clin. Invest. 111 (2003) 1309-1318
5. Beanes S.R., Dang C., Soo C., Wang Y., Urata M., Ting K., Fonkalsrud E.W., Benhaim P., Hedrick M.H., Atkinson J.B., and Lorenz H.P. Down-regulation of decorin, a transforming growth factor-beta modulator, is associated with scarless fetal wound healing. J. Pediatr. Surg. 36 (2001) 1666-1671
6. Beanes S.R., Hu F.Y., Soo C., Dang C.M., Urata M., Ting K., Atkinson J.B., Benhaim P., Hedrick M.H., and Lorenz H.P. Confocal microscopic analysis of scarless repair in the fetal rat: defining the transition. Plast. Reconstr. Surg. 109 (2002) 160-170
7. Berry D., Harding K.G., Stanton M.R., Jasani B., and Ehrlich H.P. Human wound contraction: collagen organization, fibroblasts, and myofibroblasts. Plast. Reconstr. Surg. 102 (1998) 124-131
8. Booza C., Munoz A., and Amate J.M. Efficacy of modern dressings in the treatment of leg ulcers: a systematic review. Wound Rep. Reg. 13 (2005) 218-229
9. Bullard K.M., Longaker M.T., and Lorenz H.P. Fetal wound healing: current biology. World J. Surg. 27 (2003) 54-61
10. Caravaggi C., De Giglio R., Pritelli C., Sommaria M., Dalla Noce S., Faglia E., Mantero M., Clerici G., Fratino P., Dalla Paola L., Mariani G., Mingardi R., and Morabito A. HYAFF 1-based autologous dermal and epidermal grafts in the treatment of noninfected diabetic plantar and dorsal foot ulcers. Diabetes Care 26 (2003) 2853-2859
11. Cass D.L., Meuli M., and Adzick N.S. Scar wars: implications of fetal wound healing for the pediatric burn patient. Pediatr. Surg. 12 (1997) 484-489
12. Cavallini M. Autologous fibroblasts to treat deep and complicated leg ulcers in diabetic patients. Wound Rep. Reg. 15 (2007) 35-38
13. Chaby G., Viseux V., Ramelet A.A., Ganry O., Billet A., and Lok C. Refractory venous or arteriovenous leg ulcers: a multifactorial origin. Dermatol. Surg. 32 (2006) 512-519
14. Chen W., Fu X., Ge S., Sun T., Zhou G., Han B., Li H., and Sheng Z. Profiling of genes differentially expressed in a rat of early and later gestational ages with high-density oligonuclotide DNA array. Wound Rep. Regen. 15 (2007) 147-155
15. Christman K.L., Fang Q., Kim A.J., Sievers R.E., Fok H.H., Candia A.F., Colley K.J., Herradon G., Ezquerra L., Deuel T.F., and Lee R.J. Pleiotrophin induces formation of functional neovaculature in vivo. Biochem. Biophys. Res. Commun. 332 (2005) 1146-1152
16. Constant J.S., Bullard K.M., Hunt T.K., and Longaker M.T. Increased vascular endothelial growth factor in hypoxic fetal wounds. Surg. Forum 48 (1997) 519-521
17. Dang C., Ting K., Soo C., Longaker M.T., and Lorenz H.P. Fetal wound healing current perspectives. Clin. Plast. Surg. 30 (2003) 13-23
18. de Buys Roessingh A., Hohlfeld J., Scaletta C., Hirt-Burri N., Gerber S., Hohlfeld P., and Applegate L.A. Development and Characterization of a fetal skin bank for tissue engineering and its clinical application for acute and chronic wounds. Cell Transplant. 15 (2006) 823-834
19. De Cat B., and David G. Developmental roles of the glypicans. Cell Develop. Biol. 12 (2001) 117-125
20. Dennis Jr. G., Sherman B.T., Hosack D.A., Yang J., Gao W., Lane H.C., and Lempicki R.A. DAVID: database for annotation, visualization, and integrated discovery. Genome Biol. 4 5 (2003) P3
21. Eklöf B., Rutherford R.B., Bergan J.J., Carpentier P.H., Gloviczki P., Kistner R.L., Meissner M.H., Moneta G.L., Myers K., Padberg F.T., Perrin M., Vaughan Ruckley C., Coleridge Smith P., Wakefield T.W., for the American Venous Forum International Ad Hoc Committee for Revision of the CEAP Classification, Helsingborg, and Sweden. Revision of the CEAP classification for chronic venous disorders: consensus statement. J. Vasc. Surg. 40 (2004) 1248-1252
22. Falanga V., Margolis D., Alvarez O., Auletta M., Maggiacomo F., Altman M., Jensen J., Sabolinski M., Hardin-Young J., and the Human Skin Equivalent Investigators Group. Rapid healing of venous ulcers and lack of clinical rejection with an allogeneic cultured human skin equivalent. Arch. Dermatol. 134 (1998) 293-300
23. Gulliver, S.C., Ruckshanthi, J.P.D., Hardman, M.J., Nakayama, T., Ashcroft, G.S., in press. Sex dimorphism in wound healing: the roles of sex steroids and macrophage migration inhibitory factor. Endocrinology, 10.1210/en.2008-0355.
24. Hafner J., Ramelet A.A., Schmeller W., and Brunner U. Management of leg ulcers. Curr. Prob. Dermatol. 27 (1999) 4-7
25. Hallock G.G., Merkel J.R., Rice D.C., and DiPaolo B.R. The ontogenetic transition of collagen deposition in rat skin. Ann. Plast. Surg. 30 (1993) 239-243
26. Hirt-Burri N., Scaletta C., Gerber S., Pioletti D., and Applegate L.A. Wound-healing gene family expression differences between fetal and foreskin cells used for bioengineered skin substitutes. Artif. Organs 32 (2008) 509-518
27. Hohlfeld J., De Buys Roessingh A., Hirt-Burri N., Chaubert P., Gerber S., Scaletta C., Hohlfeld P., and Applegate L.A. Tissue engineered fetal skin constructs for paediatric burns. Lancet 366 (2005) 840-842
28. Hwang E.A., Lee H.-B., and Tark K.C. Comparison of bone morphogenic protein receptors expression in the fetal and adult skin. Yonsei Med. J. 42 (2001) 581-586
29. Kahn S.R., M'Ian C.E., Lamping D.L., Kurtz X., Berard A., and Abenhaim L.A. Relationship between clinical classification of chronic venous disease and patient-reported quality of life: Results from an international cohort study. J. Vasc. Surg. 39 (2004) 823-828
30. Khachemoune A., Bello Y.M., and Phillips T.J. Factors that influence healing in chronic venous ulcers treated with crypreserved human epidermal cultures. Dermatol. Surg. 28 (2002) 274-280
31. Krummel T.M., Michna B.A., Thomas B.L., Sporn M.B., Nelson J.M., Salzberg A.M., Cohen I.K., and Diegelmann R.F. Transforming growth factor beta (TGF-beta) induces fibrosis in a fetal wound model. J. Pediatr. Surg. 23 (1988) 647-652
32. Lee J.J., Roy N., Mogford J.E., Schiemann W.P., and Mustoe T.A. Fibulin-5 promotes wound healing in vivo. J. Am. Coll. Surg. 199 (2004) 403-410
33. Lener T., Moll P.R., Rinnerthaler M., Bauer J., Aberger F., and Richter K. Expression profiling of aging in the human skin. Exp. Gerontol. 41 (2006) 387-397
34. Limat A., Mauri D., and Hunziker T. Successful treatment of chronic leg ulcers with epidermal equivalents generated from cultured autologous outer root sheath cells. J. Invest. Dermatol. 107 (1996) 128-135
35. Lin R.Y., Sullivan K.M., Argenta P.A., Meuli M., Lorenz H.P., and Adzick N.S. Exogenous transforming growth factor-beta amplifies its own expression and induces scar formation in a model of human fetal skin repair. Ann. Surg. 222 (1995) 146-154
36. -ΔΔCT method. Methods 25 (2001) 402-408
37. Lorenz H.P., Lin R.Y., Longaker M.T., Whitby D.J., and Adzick N.S. The fetal fibroblast: the effector cell of scarless fetal skin repair. Plast. Reconstr. Surg. 96 (1995) 1251-1259 discussion 1260-1251
38. Mansourian R., Mutch D.M., Antille N., Aubert J., Fogel P., Le Goff J.M., Moulin J., Petrov A., Rytz A., Voegel J.J., and Roberts M.A. The Global Error Assessment (GEA) model for the selection of differentially expressed genes in microarray data. Bioinformatics 20 (2004) 2726-2737
39. Marklund B., Sülau T., and Lindholm C. Prevalence of non-healed and healed chronic leg ulcers in an elderly rural population. Scan. J. Health Care 18 (2000) 58-60
40. Marston W.A., Hanft J., Noorwood P., and Pollak P. Dermagraft Diabetic Foot Ulcer Study Group. The efficacy and safety of Dermagraft in improving the healing of chronic diabetic foot ulcers: results of a prospective randomized trial. Diabetes Care 26 (2003) 1701-1705
41. Mast B.A., Diegelmann R.F., Krummel T.M., and Cohen I.K. Hyaluronic acid modulates proliferation, collagen and protein synthesis of cultured fetal fibroblasts. Matrix 13 (1993) 441-446
42. Mutch D.M., Berger A., Mansourian R., Rytz A., and Roberts M.A. The limit fold change model: a practical approach for selecting differentially expressed genes from microarray data. BMC Bioinform. 3 (2002) 17
43. Nakamura N., Yamamoto M., Oda E., Yamamoto A., Kanemura Y., Hara M., Suzuki A., Yamasaki M., and Okano H. Expression of tubulin beta II in neural stem/progenitor cells and radial fibers during human fetal brain development. Lab Invest. 83 (2003) 479-489
44. Peled Z.M., Rhee S.J., Hsu M., Chang J., Krummel T.M., and Longaker M.T. The ontogeny of scarless healing II: EGF and PDGF-B gene expression in fetal rat skin and fibroblasts as a function of gestational age. Ann. Plast. Surg. 47 (2001) 417-424
45. Quintin A., Hirt-Burri N., Scaletta C., Schizas C., Pioletti D., and Applegate L.A. Consistency and safety of fetal cell banks for research and clinical use: preliminary analysis of fetal skin banks. Cell Transplant. 16 (2007) 675-684
46. Ragnarson T.G., and Hjelmgren J. Annual costs of treatment for venous leg ulcers in Sweden and the United Kingdom. Wound Repair Regen. 13 (2005) 13-18
47. Ramelet A.-A., Scaletta C., Rocque S., Hohlfeld P., Burri N., and Applegate L.A. Three-Dimensional Cutaneous Tissue Engineering for the Treatment of Acute and Chronic Wounds. Dermatology 203 (2001) 89-107
48. Sandulache V.C., Dohar J.E., and Hebda P.A. Adult-fetal fibroblast interactions: effects on cell migration and implications for cell transplantation. Cell Transplant. 14 (2005) 331-337
49. Sandulache V.C., Parekh A., Dohar J.E., and Hebda P.A. Fetal dermal fibroblasts retain a hyperactive migratory and contractile phenotype under 2- and 3-dimensional constraints compared to normal adult fibroblasts. Tissue Eng. 13 (2007) 2791-2801
50. Soo C., Hu F.-Y., Zhang X., Lorenz H.P., Hedrick M.H., Mackool R.J., Plaas A., Kim S.-K., Longaker M.T., Freymiller E., and Ting K. Differential expression of fibromodulin, a transforming growth factor-β modulatore, in fetal skin development and scarless repair. Am. J. Path. 157 (2000) 423-433
51. Soo C., Sayah D.N., Zhang X., Beanes S.R., Nishimura I., Dang C., Freymiller E., and Ting K. The identification of novel wound-healing genes through differential display. Plast. Reconstr. Surg. 110 (2002) 787-797
52. Sullivan K.M., Lorenz H.P., and Adzick N.S. The role of TGFb in human fetal wound healing. Surg. Forum. 44 (1993) 625-627
53. Uccioli L. TissueTech Autograph System Italian Study Group. A clinical investigation of the characteristics and outcomes of treating chronic lower extremity wounds using the tissuetech autograft system. Int. J. Low. Extrem. Wounds 2 (2003) 140-151
54. Vooijs D.P., Walboomers X.F., Parker J.A., Von den Hoff J.W., and Jansen J.A. Transforming growth factor-beta3-loaded microtextured membranes for skin regeneration in dermal wounds. J. Biomed. Mater. Res. 70A (2004) 402-411
55. Werner S., and Grose R. Regulation of wound healing by growth factors and cytokines. Physiol. Rev. 83 (2003) 835-870
56. Wu L., Siddiqui A., Morris D.E., Cox D.A., Roth S.I., and Mustoe T.A. Transforming growth factor beta 3 (TGF beta 3) accelerates wound healing without alteration of scar prominence. Histologic and competitive reverse-transcription-polymerase chain reaction studies. Arch. Surg. 132 (1997) 753-760
57. Yang G.P., Lim I.J., Phan T.T., Lorenz H.P., and Longaker M.T. From scarless fetal wounds to keloids: molecular studies in wound healing. Wound Repair Regen. 11 (2003) 411-418